Xiaobei Mao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Chemokine receptors and signaling
Papers in
-
- FOXO transcription factor regulation 4
- Glycosylation and Glycoproteins Research 1
- Epigenetics and DNA Methylation 1
- Oncology 5
- Chemokine receptors and signaling 2
- Co-authors
- Lijun Xue (11 shared papers)Xiaoyuan Chu (10 shared papers)Longbang Chen (6 shared papers)Lili Ren (3 shared papers)Kai Xu (2 shared papers)Tao Xie (2 shared papers)Rui Wang (1 shared paper)Lijun Xue (1 shared paper)
- Journals
- Cancer Medicine (2 papers)Cellular Physiology and Biochemistry (2 papers)Oncotarget (1 paper)Cancer Biology & Therapy (1 paper)PLoS ONE (1 paper)
- Partner nations
- China
In The Last Decade
Xiaobei Mao
12 papers receiving 376 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 138
- Oncology 101
- Molecular Biology 222
- Immunology 48
- Pathology and Forensic Medicine 23
Countries citing papers authored by Xiaobei Mao
This map shows the geographic impact of Xiaobei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobei Mao more than expected).
Fields of papers citing papers by Xiaobei Mao
This network shows the impact of papers produced by Xiaobei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobei Mao. The network helps show where Xiaobei Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobei Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 76 | |
| 2 | 2017 | 67 | |
| 3 | 2016 | 62 | |
| 4 | 2016 | 59 | |
| 5 | 2014 | 37 | |
| 6 | Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance. | 2015 | 21 |
| 7 | 2018 | 20 | |
| 8 | 2019 | 18 | |
| 9 | 2021 | 14 | |
| 10 | 2024 | 2 | |
| 11 | 2017 | 2 | |
| 12 | [Genome-wide screening of CpG island methylation changes induced by low-dose X-ray radiation in mice]. | 2014 | 1 |
| 13 | 2010 | 0 |
About Xiaobei Mao
Xiaobei Mao is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Pathology and Forensic Medicine, having authored 13 papers that have together received 379 indexed citations. Recurring topics across this work include FOXO transcription factor regulation (4 papers), Immunotherapy and Immune Responses (2 papers), Chemokine receptors and signaling (2 papers), Cancer Mechanisms and Therapy (1 paper), Glycosylation and Glycoproteins Research (1 paper), Epigenetics and DNA Methylation (1 paper), Galectins and Cancer Biology (1 paper) and Childhood Cancer Survivors' Quality of Life (1 paper). The work is most often cited by research in Cancer Research (138 citations), Oncology (101 citations), Molecular Biology (222 citations), Immunology (48 citations) and Pathology and Forensic Medicine (23 citations). Xiaobei Mao has collaborated with scholars based in China. Frequent co-authors include Lijun Xue, Xiaoyuan Chu, Longbang Chen, Lili Ren, Kai Xu, Tao Xie, Rui Wang, Lijun Xue, Tingting Dai and Jian Geng. Their work appears in journals such as Cancer Medicine, Cellular Physiology and Biochemistry, Oncotarget, Cancer Biology & Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.